Is TRPA1 <i>Burning Down</i> TRPV1 as Druggable Target for the Treatment of Chronic Pain?

Is TRPA1 <i>Burning Down</i> TRPV1 as Druggable Target for the Treatment of Chronic Pain?

Over the last decades, a great array of molecular mediators have been identified as potential targets for the treatment of chronic pain. Among these mediators, transient receptor potential (TRP) channel superfamily members have been thoroughly studied. Namely, the nonselective cationic channel, tran...

Full description

Bibliographic Details
Main Authors: Simona Giorgi, Magdalena Nikolaeva-Koleva, David Alarcón-Alarcón, Laura Butrón, Sara González-Rodríguez
Format: Article
Language:English
Published: MDPI AG 2019-06-01
Series:International Journal of Molecular Sciences
Subjects:
TRPA1
pain
inflammation
neuropathy
molecular modulation
Online Access:https://www.mdpi.com/1422-0067/20/12/2906

Internet

https://www.mdpi.com/1422-0067/20/12/2906

Similar Items